David Hardwicke

Co-Founder at Aerska

Speaker

David Hardwicke is Co-Founder and Head of Business Development at Aerska, a company advancing brain shuttle–enabled RNA medicines for CNS disorders. His background spans biotech entrepreneurship, venture investing, and commercialization across cell and gene therapy and RNA therapeutics, with prior roles at AveXis (now Novartis Gene Therapies), ONK Therapeutics, and Pathway Bioventures. He holds degrees from the University of Notre Dame, US and University College Cork, Ireland.